Results 11 to 20 of about 5,120 (267)

PET/MR: a paradigm shift [PDF]

open access: yesCancer Imaging, 2013
More than a decade ago, multimodality imaging was introduced into clinical routine with the development of the positron emission tomography (PET)/computed tomography (CT) technique. Since then, PET/CT has been widely accepted in clinical imaging and has emerged as one of the main cancer imaging modalities.
Florian C. Gaertner   +2 more
openaire   +3 more sources

Design and system evaluation of a dual-panel portable PET (DP-PET)

open access: yesEJNMMI Physics, 2021
Background Integrated whole-body PET/MR technology continues to mature and is now extensively used in clinical settings. However, due to the special design architecture, integrated whole-body PET/MR comes with a few inherent limitations.
Tianyi Zeng   +10 more
doaj   +1 more source

Human Papillomavirus Status and the Risk of Cerebrovascular Events Following Radiation Therapy for Head and Neck Cancer

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundRadiation therapy (RT) is a standard treatment for head and neck cancer; however, it is associated with inflammation, accelerated atherosclerosis, and cerebrovascular events (CVEs; stroke or transient ischemic attack). Human papillomavirus (HPV)
Daniel Addison   +12 more
doaj   +1 more source

Comparison of Nasopharyngeal MR, 18 F-FDG PET/CT, and 18 F-FDG PET/MR for Local Detection of Natural Killer/T-Cell Lymphoma, Nasal Type

open access: yesFrontiers in Oncology, 2020
ObjectivesThe present study aims to compare the diagnostic efficacy of MR, 18F-FDG PET/CT, and 18F-FDG PET/MR for the local detection of early-stage extranodal natural killer/T-cell lymphoma, nasal type (ENKTL).Patients and MethodsThirty-six patients ...
Rui Guo   +14 more
doaj   +1 more source

Analysis of Progress and Challenges of EGFR-Targeted Molecular Imaging in Cancer With a Focus on Affibody Molecules

open access: yesMolecular Imaging, 2019
Epidermal growth factor receptor (EGFR)-targeted cancer therapy requires an accurate estimation of EGFR expression in tumors to identify responsive patients, monitor therapeutic effect, and estimate prognosis.
Weizhi Chen MD   +2 more
doaj   +1 more source

Correlation between 18F-FDG PET/MR parameters with the expression level of epidermal growth factor receptor and the diagnostic value of PET/MR in head and neck squamous cell carcinoma

open access: yesHeliyon, 2023
Objective: To investigate the correlation between parameters of PET/MR and the expression level of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinoma (HNSCC) and to evaluate diagnostic efficacy of independent and combined ...
Yu Chen   +11 more
doaj   +1 more source

Feasibility of Total Variation Noise Reduction Algorithm According to Various MR-Based PET Images in a Simultaneous PET/MR System: A Phantom Study

open access: yesDiagnostics, 2021
Recently, the total variation (TV) algorithm has been used for noise reduction distribution in degraded nuclear medicine images. To acquire positron emission tomography (PET) to correct the attenuation region in the PET/magnetic resonance (MR) system ...
Chan-Rok Park   +2 more
doaj   +1 more source

Comparison of absorbed dose extrapolation methods for mouse-to-human translation of radiolabelled macromolecules

open access: yesEJNMMI Research, 2022
Background Extrapolation of human absorbed doses (ADs) from biodistribution experiments on laboratory animals is used to predict the efficacy and toxicity profiles of new radiopharmaceuticals.
Francesco Cicone   +5 more
doaj   +1 more source

Comparison of PET image quality using simultaneous PET/MR by attenuation correction with various MR pulse sequences

open access: yesNuclear Engineering and Technology, 2019
Positron emission tomography (PET)/magnetic resonance (MR) scanning has the advantage of less additional exposure to radiation than does PET/computed tomography (CT).
Chan Rok Park, Youngjin Lee
doaj   +1 more source

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background People living with HIV (PHIV) are at an increased risk for sudden cardiac death, and implantable cardioverter‐defibrillators (ICDs) prevent SCD. There are no data on the incidence, predictors, and effects of ICD therapies among PHIV.
Raza M. Alvi   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy